Previous close | 131.03 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 141.89 x N/A |
Day's range | 135.50 - 135.50 |
52-week range | 89.00 - 148.00 |
Volume | |
Avg. volume | 1 |
Market cap | 132.142B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.47 (3.30%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
Koninklijke Philips N.V. (NYSE:PHG) has reportedly taken legal action against SoClean to allocate a portion of the recent $1.1 billion settlement concerning alleged injuries caused by Philips’ recalled devices. In June 2021, Philips initiated a voluntary recall notification for certain CPAP and BiPAP sleep therapy devices and ventilators related to the polyester-based polyurethane (PE-PUR) sound abatement foam in these devices that were harmful to the users. Last month, the Dutch medical technol
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
PHG vs. HAE: Which Stock Is the Better Value Option?